Anti Thymocyte Globulin + GM-CSF + Total Body Irradiation + ALEMTUZUMAB + RITUXIMAB + HUMAN IMMUNOGLOBULIN G + Cyclophosphamide + THIOTEPA + Mesna for lung diseases, interstitial
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Put together by software, not yet checked by a person
Why this status
31 Jul 2018: Trial started, NCT03630211
14 Aug 2018: Trial registered, NCT03630211
The trials
NCT03630211: Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
State
Under way
Phase
Phase 2
People
8 planned
Started
31 Jul 2018
Primary completion
1 Aug 2028
Arms
Autologous Stem Cell Transplantation
Results
None posted
31 Jul 2018: Trial started
14 Aug 2018: Trial registered
How the status changed
19 Nov 2026: First set: Phase 2 trial
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.